APO PHARM ApS: Financial statements 2014
CVR: 15226072
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
APO PHARM ApS (CVR 15226072) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 1,031,530 and a net result of DKK -20,165 compared with DKK -125,559 the year before. That is an increase of 31.8% compared with the year before. Equity in the 2014 report amounted to DKK 170,940. The solvency ratio was 20.6%.
- Gross Profit
- DKK 1,031,530
- Profit/Loss
- DKK -20,165
- Equity
- DKK 170,940
- Total Assets
- DKK 827,974
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 1 mio. | -20 t. | 171 t. | - |
| 2013 | - | 783 t. | -126 t. | 191 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of November 28, 2014, Hanne Vesti Petersen has joined the board of directors of APO PHARM ApS.
As of November 28, 2014, Kresten Mikael Valdal has left the board of directors of APO PHARM ApS.
About APO PHARM ApS
APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.